Spero Therapeutics, Inc. Operating Lease, Expense
Spero Therapeutics, Inc. (SPRO) reported Operating Lease, Expense of $400.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-11-05
- Spero Therapeutics, Inc. operating lease, expense for the quarter ending 2020-09-30 was $400.00K.
- Spero Therapeutics, Inc. operating lease, expense for the quarter ending 2020-06-30 was $300.00K.
- Spero Therapeutics, Inc. operating lease, expense for the quarter ending 2020-03-31 was $200.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month |
|---|---|---|---|
| 2020-09-30 | $400.00K 10-Q · filed 2020-11-05 | $700.00K derived: sum of 2 quarters · filed 2020-11-05 | $900.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $300.00K 10-Q · filed 2020-08-06 | $500.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $200.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |